Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  2013-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neubiorev.2012.12.005PMID 23253944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.

  2013cited by this paper
• Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine‐induced cognitive deficits in mice

  2013cited by this paper
• In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.

  2013influential reference
• The regulation of N‐methyl‐d‐aspartate receptors by Src kinase

  2012cited by this paper
• Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine

  2012influential reference
• Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders.

  2012cited by this paper
• Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.

  2012influential reference
• Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

  2012influential reference
• GABAergic interneuron origin of schizophrenia pathophysiology.

  2012cited by this paper
• Preso1 dynamically regulates group I metabotropic glutamate receptors

  2012cited by this paper
• The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.

  2012cited by this paper
• Biological perspectives: the role of glutamate in schizophrenia and its treatment.

  2012cited by this paper
• Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu5 Positive Allosteric Modulator

  2012cited by this paper
• TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.

  2012cited by this paper
• Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.

  2011cited by this paper
• Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.

  2011cited by this paper
• mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch.

  2011cited by this paper
• Addressing side effects from antipsychotic treatment in schizophrenia.

  2011cited by this paper
• Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneurons

  2011cited by this paper
• Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.

  2011cited by this paper
• Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.

  2011cited by this paper
• A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

  2011cited by this paper
• Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator.

  2011cited by this paper
• Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.

  2011cited by this paper
• Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia.

  2011cited by this paper
• Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.

  2011cited by this paper
• esearch report-methyl-d-aspartate ( NMDA ) receptor dysfunction or dysregulation : The final ommon pathway on the road to schizophrenia ?

  2010cited by this paper
• Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions.

  2010cited by this paper
• The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.

  2010influential reference
• Discovery of N-Aryl Piperazines as Selective mGluR5 Potentiators with Improved In Vivo Utility

  2010cited by this paper
• Adolescent chronic apomorphine treatment impairs latent inhibition and reduces prefrontal cortex mGluR5 receptor expression in adult rats.

  2010cited by this paper
• Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity

  2010cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?

  2010cited by this paper
• Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia.

  2010cited by this paper
• Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?

  2010cited by this paper
• Discovery of N-Aryl Piperazines as Selective mGlu(5) Potentiators with Efficacy in a Rodent Model Predictive of Anti-Psychotic Activity.

  2010cited by this paper
• Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia.

  2010cited by this paper
• Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator.

  2010cited by this paper
• An integrated view on the role of receptor mosaics at perisynaptic level: focus on adenosine A2A, dopamine D2, cannabinoid CB1, and metabotropic glutamate mGlu5 receptors

  2010cited by this paper
• Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade.

  2010cited by this paper
• Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed‐release formulation – results from two randomized controlled studies

  2009cited by this paper
• Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.

  2009cited by this paper
• Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.

  2009cited by this paper
• Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling

  2009influential reference
• Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.

  2009influential reference
• Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.

  2009influential reference
• NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.

  2009cited by this paper
• Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia

  2009cited by this paper
• mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

  2009cited by this paper
• Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice

  2008cited by this paper
• Calmodulin dynamically regulates the trafficking of the metabotropic glutamate receptor mGluR5

  2008cited by this paper
• Protective effects of extract of Coeloglossum viride var. bracteatum on ischemia-induced neuronal death and cognitive impairment in rats

  2008cited by this paper
• ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

  2008cited by this paper
• Homer Interactions Are Necessary for Metabotropic Glutamate Receptor-Induced Long-Term Depression and Translational Activation

  2008cited by this paper
• Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.

  2008cited by this paper
• Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia

  2008cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Molecular Mechanisms of Schizophrenia

  2007cited by this paper
• Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.

  2007cited by this paper
• Dopamine hypothesis of schizophrenia: Making sense of it all

  2007cited by this paper
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co‐expressed on rat and human noradrenergic terminals

  2007cited by this paper
• Metabotropic glutamate receptors in stem/progenitor cells.

  2007cited by this paper
• Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors

  2007cited by this paper
• Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.

  2007cited by this paper
• Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis.

  2007cited by this paper
• Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

  2007cited by this paper
• Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats.

  2007influential reference
• Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors.

  2006cited by this paper
• Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory.

  2006cited by this paper
• A Specific Role for NR2A-Containing NMDA Receptors in the Maintenance of Parvalbumin and GAD67 Immunoreactivity in Cultured Interneurons

  2006cited by this paper
• The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices.

  2006influential reference
• Coupling of Agonist Binding to Effector Domain Activation in Metabotropic Glutamate-like Receptors*

  2006cited by this paper
• Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition

  2006cited by this paper
• Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists

  2005cited by this paper
• mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.

  2005influential reference
• A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models

  2005cited by this paper
• Neurodevelopment, neuroplasticity, and new genes for schizophrenia.

  2005cited by this paper
• Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

  2005cited by this paper
• Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.

  2005cited by this paper
• NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin.

  2005cited by this paper
• Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin*

  2005cited by this paper
• The neurodevelopmental model of schizophrenia: update 2005

  2005cited by this paper
• Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

  2004cited by this paper
• Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.

  2004cited by this paper
• The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

  2004cited by this paper
• Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

  2004cited by this paper
• The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats

  2004cited by this paper
• Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.

  2003cited by this paper
• Comparing protein abundance and mRNA expression levels on a genomic scale

  2003cited by this paper
• Glutamatergic mechanisms in schizophrenia.

  2003influential reference
• Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism

  2003cited by this paper
• The neurodevelopmental hypothesis of schizophrenia: a review of recent developments

  2003cited by this paper
• G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression.

  2003cited by this paper
• Modulation of synaptic signalling complexes by Homer proteins

  2002cited by this paper
• Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain

  2002cited by this paper
• Two Distinct Signaling Pathways Upregulate NMDA Receptor Responses via Two Distinct Metabotropic Glutamate Receptor Subtypes

  2002cited by this paper
• Tamalin, a PDZ Domain-Containing Protein, Links a Protein Complex Formation of Group 1 Metabotropic Glutamate Receptors and the Guanine Nucleotide Exchange Factor Cytohesins

  2002cited by this paper
• Atypical Antipsychotics: Mechanism of Action

  2002cited by this paper

• Distinct structural deficits in treatment-resistant schizophrenia and their putative neurotransmitter basis: a source-based morphometry analysis

  2025cites this paper
• Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations

  2025cites this paper
• Investigation of the Roles of the Adenosine A(2A) and Metabotropic Glutamate Receptor Type 5 (mGlu5) Receptors in Prepulse Inhibition and CREB Signaling in a Heritable Rodent Model of Psychosis

  2025cites this paper
• IUPHAR REVIEW: Moving beyond dopamine-based therapeutic strategies for schizophrenia.

  2025cites this paper
• Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder

  2025cites this paper
• Epitope Identification of an mGlu5 Receptor Nanobody Using Physics-Based Molecular Modeling and Deep Learning Techniques

  2024cites this paper
• The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats.

  2024cites this paper
• The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

  2024cites this paper
• Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders

  2024cites this paper
• Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia

  2024cites this paper
• Metabotropic glutamate receptors in Parkinson's disease.

  2023cites this paper
• GRIN2B gene expression is increased in the anterior cingulate cortex in major depression.

  2023cites this paper
• Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

  2023cites this paper
• Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks

  2023cites this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cites this paper
• Loss of schizophrenia-related miR-501-3p in mice impairs sociability and memory by enhancing mGluR5-mediated glutamatergic transmission

  2022cites this paper
• Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders

  2022cites this paper
• The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.

  2022cites this paper
• Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers

  2021cites this paper
• Association of Glutamate Receptor Metabotropic 5 Gene (Grm5) Polymorphisms With Schizophrenia Susceptibility and Symptoms in a Chinese-Han Population

  2021cites this paper
• Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study

  2021cites this paper
• Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

  2021cites this paper
• Excitatory amino acid transporter (EAAT)1 and EAAT2 mRNA levels are altered in the prefrontal cortex of subjects with schizophrenia.

  2020cites this paper
• The effects of perinatal fluoxetine exposure on emotionality behaviours and cortical and hippocampal glutamatergic receptors in female Sprague-Dawley and Wistar-Kyoto rats.

  2020cites this paper
• A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis.

  2020cites this paper
• mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity

  2019cites this paper
• Regulation and Function of Activity-Dependent Homer in Synaptic Plasticity

  2019cites this paper
• Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating

  2019cites this paper
• Distinct Time-Course of Alterations of Groups I and II Metabotropic Glutamate Receptor and GABAergic Receptor Expression Along the Dorsoventral Hippocampal Axis in an Animal Model of Psychosis

  2019cites this paper
• Involvement of metabotropic glutamate receptor 5 in ethanol regulation of NMDA receptor activity in rat substantia gelatinosa neurons.

  2019cites this paper
• Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment

  2019cites this paper
• Adenosine A2A receptors are required for glutamate mGluR5‐ and dopamine D1 receptor‐evoked ERK1/2 phosphorylation in rat hippocampus: involvement of NMDA receptor

  2018cites this paper
• Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices.

  2018cites this paper
• Cellular / Molecular Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors

  2018cites this paper
• Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia).

  2018cites this paper
• Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression

  2018influential citation
• mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia

  2018cites this paper
• Drugs to Tune Up Glutamatergic Systems: Modulators of Glutamate Metabotropic Receptors

  2018cites this paper
• Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors

  2018cites this paper
• Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain

  2017cites this paper
• Activated mGluR5 protects BV2 cells against OGD/R induced cytotoxicity by modulating BDNF-TrkB pathway.

  2017cites this paper
• Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.

  2017influential citation
• Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies

  2017cites this paper
• Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.

  2017cites this paper
• Metabotropic glutamate receptor, mGlu5, mediates enhancements of hippocampal long‐term potentiation after environmental enrichment in young and old mice

  2017cites this paper
• Attention regulation and behavioural flexibility in rats with relevance to schizophrenia

  2017cites this paper
• The role of schizophrenia susceptibility genes in associative learning

  2016cites this paper
• Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.

  2016cites this paper
• Pu-erh Tea Protects the Nervous System by Inhibiting the Expression of Metabotropic Glutamate Receptor 5

  2016cites this paper
• Group 1 metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex

  2016cites this paper
• Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment

  2016cites this paper
• Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression

  2016cites this paper
• Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias

  2016cites this paper
• Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging

  2016cites this paper
• The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease.

  2016cites this paper
• Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

  2016cites this paper
• Novel Targets for Drug Treatment in Psychiatry

  2016cites this paper
• Enantioselective Synthesis of a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 5 (mGluR5) Receptor via Dynamic Kinetic Resolution of α-Amino Ketones

  2016cites this paper
• The Evolutionary Etiologies of Autism Spectrum and Psychotic Affective Spectrum Disorders

  2016cites this paper
• The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models

  2016cites this paper
• Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).

  2016cites this paper
• Metabotropic glutamate receptor mGluR 2 / 3 and mGluR 5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression , bipolar disorder and schizophrenia : implications for novel mGluR-based therapeutics

  2016cites this paper
• Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.

  2015cites this paper
• Drug development in schizophrenia: are glutamatergic targets still worth aiming at?

  2015cites this paper
• Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.

  2015cites this paper
• Relevance of the metabotropic glutamate receptor (mGluR5) in the regulation of NREM-REM sleep cycle and homeostasis: evidence from mGluR5 (-/-) mice.

  2015cites this paper
• Glutamatergic agents for schizophrenia: current evidence and perspectives

  2015cites this paper
• Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.

  2015cites this paper
• Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice.

  2015cites this paper
• Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation

  2015influential citation
• Exploring mGluR5 dysregulation in schizophrenia: from gene to protein

  2015cites this paper
• Title : Metabotropic glutamate receptor 5 : a candidate in psychiatric pathology ? Implications for novel mGluR 5-based therapeutics

  2014influential citation
• Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.

  2014cites this paper
• Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics

  2014influential citation
• Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia

  2014cites this paper
• Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders

  2014cites this paper
• Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5

  2014cites this paper
• Positive allosteric modulators for mGluR2 receptors: a medicinal chemistry perspective.

  2014cites this paper
• Central injection of L- and D-aspartate attenuates isolation-induced stress behavior in chicks possibly through different mechanisms.

  2014cites this paper
• Antipsychotic treatment modulates glutamate transport and NMDA receptor expression

  2014cites this paper
• Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia

  2014cites this paper
• The Effects of Microsatellite Selection on Linked Sequence Diversity

  2014influential citation
• The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue

  2014cites this paper
• Trisubstituted imidazoles as positive modulators of metabotropic glutamate receptor subtype 5.

  2013cites this paper
• Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.

  2013cites this paper
• Developmental heterochrony and the evolution of autistic perception, cognition and behavior

  2013cites this paper
• Metabotropic glutamate receptor 5 in schizophrenia: emerging evidence for the development of antipsychotic drugs.

  2013cites this paper
• mGluR5 Ablation in Cortical Glutamatergic Neurons Increases Novelty-Induced Locomotion

  2013cites this paper
• Impaired metabotropic glutamate type 5 receptor signaling in the dorsal striatum of the R451C-neuroligin 3 mouse model of Autism Spectrum Disorder

  year unknowncites this paper
• author-version of: Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction

  year unknowncites this paper